153 related articles for article (PubMed ID: 37717657)
1. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer.
Ding Q; Tang W; Li X; Ding Y; Chen X; Cao W; Wang X; Mo W; Su Z; Zhang Q; Guo H
J Control Release; 2023 Nov; 363():221-234. PubMed ID: 37717657
[TBL] [Abstract][Full Text] [Related]
2. In Situ Vaccination with Mitochondria-Targeting Immunogenic Death Inducer Elicits CD8
Wang Y; Wang W; Gu R; Chen J; Chen Q; Lin T; Wu J; Hu Y; Yuan A
Adv Sci (Weinh); 2023 Jul; 10(20):e2300286. PubMed ID: 37127892
[TBL] [Abstract][Full Text] [Related]
3. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
[TBL] [Abstract][Full Text] [Related]
4. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
Zhang S; Kang L; Dai X; Chen J; Chen Z; Wang M; Jiang H; Wang X; Bu S; Liu X; Zhang G; Tang H
Free Radic Biol Med; 2022 Nov; 193(Pt 1):202-212. PubMed ID: 36228830
[TBL] [Abstract][Full Text] [Related]
5. Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis.
Deng Z; Li B; Yang M; Lu L; Shi X; Lovell JF; Zeng X; Hu W; Jin H
J Nanobiotechnology; 2024 May; 22(1):225. PubMed ID: 38705987
[TBL] [Abstract][Full Text] [Related]
6. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
[TBL] [Abstract][Full Text] [Related]
7. A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy.
Yang J; Xiong W; Huang L; Li Z; Fan Q; Hu F; Duan X; Fan J; Li B; Feng J; Xu Y; Chen X; Shen Z
J Nanobiotechnology; 2024 Apr; 22(1):204. PubMed ID: 38658948
[TBL] [Abstract][Full Text] [Related]
8. Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes.
Gao Z; Zhang J; Hou Y; Lu J; Liang J; Gao Y; Li B; Gao S; Zhao Y; Gao M; Chen J
Biomaterials; 2024 Mar; 305():122442. PubMed ID: 38142469
[TBL] [Abstract][Full Text] [Related]
9. An AND Logic Gate for Magnetic-Resonance-Imaging-Guided Ferroptosis Therapy of Tumors.
Fan Q; Xiong W; Zhou H; Yang J; Feng J; Li Z; Wu L; Hu F; Duan X; Li B; Fan J; Xu Y; Chen X; Shen Z
Adv Mater; 2023 Nov; 35(45):e2305932. PubMed ID: 37717205
[TBL] [Abstract][Full Text] [Related]
10. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
[TBL] [Abstract][Full Text] [Related]
11. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
12. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
13. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
14. Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation.
Lei L; Dong Z; Xu L; Yang F; Yin B; Wang Y; Yue R; Guan G; Xu J; Song G; Zhang XB
Theranostics; 2022; 12(14):6207-6222. PubMed ID: 36168615
[No Abstract] [Full Text] [Related]
15. Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
Feng S; Liang X; Li J; Wang Z; Zhang H; Dai Z; Luo P; Liu Z; Zhang J; Xiao X; Cheng Q
Front Immunol; 2022; 13():992855. PubMed ID: 36248827
[TBL] [Abstract][Full Text] [Related]
16. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
[TBL] [Abstract][Full Text] [Related]
17. Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties.
Ma S; Liang X; Yang N; Yang J; Zhang J; Pan X; Wei Y; Liu Z; Shen Q
Biomater Sci; 2023 Jan; 11(2):518-532. PubMed ID: 36468623
[TBL] [Abstract][Full Text] [Related]
18. A Bimetallic Polymerization Network for Effective Increase in Labile Iron Pool and Robust Activation of cGAS/STING Induces Ferroptosis-Based Tumor Immunotherapy.
Wang Z; Zhou P; Li Y; Zhang D; Chu F; Yuan F; Pan B; Gao F
Small; 2024 May; 20(20):e2308397. PubMed ID: 38072786
[TBL] [Abstract][Full Text] [Related]
19. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
20. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
